1. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin

   • Yasuhiro Yumoto
   • Masakichi Umeda
   • Takao Tsuji

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S1 - S6

2. Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries

   • Naohiko Masaki
   • Shigeki Hayashi
   • Noritsugu Umeda

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S7 - S11

3. Surgical treatment of hepatocellular carcinoma

   • Yoshifumi Kawarada
   • Fumito Ito
   • Ryuji Mizumoto

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S12 - S17

4. Hepatic resections for primary liver cancer

   • Soo Tae Kim
   • Keon Pyo Kim

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S18 - S23

5. Prognosis after hepatic resection in patients with hepatocellular carcinoma, estimated on the basis of the morphometric indices

   • Yoji Kawai
   • Kotohito Takeshige
   • Akihiko Koike

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S24 - S28

6. Regulating factors of liver regeneration after hepatectomy

   • Masayoshi Tani
   • Tomoaki Tomiya
   • Toshitsugu Oda

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 1. Surgery Pages: S29 - S32

7. Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma

   • Thomas W. T. Leung
   • Wan-yee Lau
   • Arthur K. C. Li

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 2. Combined Modalities and Others Pages: S33 - S36

8. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO)

   • Mitsuhiro Mukaiya
   • Koichi Hirata
   • Ryuichi Denno

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 2. Combined Modalities and Others Pages: S37 - S41

9. Intra-arterial alcoholization of advanced hepatocellular carcinoma

   • Kazuki Ito
   • Hiroaki Kusunoki
   • Nobuaki Nakajima

   Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 2. Combined Modalities and Others Pages: S42 - S47

10. New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases

    • Toshio Kanai
    • Morito Monden
    • Takesada Mori

    Clinical Aspects in the Treatment for Operable and Session I. Surgery, Combined Modalities and Others I. 2. Combined Modalities and Others Pages: S48 - S54

11. Evaluation of the therapeutic effect of TAE on primary liver cancer

    • Toshihiko Yamada
    • Fujio Makita
    • Masatomo Mori

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S55 - S59

12. Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results

    • Kiyoshi Nishimine
    • Hideo Uchida
    • Tadasu Tsujii

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S60 - S68

13. Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma

    • Hiromichi Oi
    • Tonsok Kim
    • Jun Okamura

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S69 - S73

14. Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma

    • Takafumi Ichida
    • Masashi Kato
    • Hitoshi Asakura

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S74 - S78

15. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE)

    • Hiraku Yodono
    • Shoichi D. Takekawa
    • Hiroshi Noda

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S79 - S83

16. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate

    • Osamu Matsui
    • Masumi Kadoya
    • Hiroshi Demachi

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-1 Pages: S84 - S88

17. Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma

    • Hironobu Nakamura
    • Takashi Mitani
    • Chikazumi Kuroda

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Pages: S89 - S92

18. Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma

    • Seishiro Watanabe
    • Mikio Nishioka
    • Cooperative Study Group for Liver Cancer Treatment in Shikoku area

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Pages: S93 - S96

19. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma—a comparison between L-TAE with Farmorubicin and L-TAE with Adriamycin: preliminary results (second cooperative study)

    • Saburo Kawai
    • Masayoshi Tani
    • The Cooperative Study Group for Liver Cancer Treatment of Japan

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Pages: S97 - S102

20. Outcomes of 116 patients with hepatocellular carcinoma

    • Hiroyoshi Onodera
    • Katsuaki Ukai
    • Tadami Shoji

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Pages: S103 - S108

21. Efficacy of CO₂-DSA in embolization

    • Yasuaki Teshima
    • Naoya Iwasaki

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 1. TAE-2 Pages: S109 - S110

22. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy

    • Yuji Horiguchi
    • Bon Sekoguchi
    • Madoka Itoh

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 2. PEI and Radiotherapy Pages: S111 - S114

23. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma

    • Toshiyuki Kato
    • Yukifumi Saito
    • Kazuei Ogoshi

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 2. PEI and Radiotherapy Pages: S115 - S118

24. Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma

    • Hideo Tateishi
    • Masakatsu Kinuta
    • Jun Okamura

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 2. PEI and Radiotherapy Pages: S119 - S123

25. The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma

    • Shinn-Cherng Chen
    • Shi-Long Lian
    • Wen-Yu Chang

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 2. PEI and Radiotherapy Pages: S124 - S127

26. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol

    • Hyung Sik Yoo
    • Chan Hee Park
    • Chan Il Park

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 2. PEI and Radiotherapy Pages: S128 - S133

27. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system

    • Takashi Iwamiya
    • Satoshi Sawada
    • Yoshio Ohta

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others Pages: S134 - S138

28. Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma

    • Motoshi Yasui
    • Toshiaki Nonami
    • Hiroshi Takagi

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others Pages: S139 - S141

29. Hepatic arterial infusion chemotherapy for liver metastases from breast cancer

    • Yasuaki Arai
    • Yasuhiro Sone
    • Choichiro Kido

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others Pages: S142 - S144

30. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma

    • Toshiyuki Suto
    • Shinsaku Fukuda
    • Yu Sakata

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others Pages: S145 - S148

31. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma

    • Masaharu Yoshikawa
    • Hiromitsu Saisho
    • Masao Ohto

    Clinical Aspects in the Treatment for Operable and Session II. Chemotherapy and Radiotherapy II. 3. Reservoir and Others Pages: S149 - S152

32. Occurrence of hepatocellular carcinoma in chronic viral hepatitis

    • Masao Omata
    • Susumu Takano

    Clinical Aspects in the Treatment for Operable and Session III. Plenary Session Pages: S153 - S154